Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform TikTok.
- SIGNA Sports United N.V. (NYSE: SSU) gained 41.6% to $1.23.
- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 33.2% to $0.2864. Novo Integrated Sciences recently announced it received an Underwriting Clearance Notice for a $70 million coupon.
- Cellectar Biosciences, Inc. (NASDAQ: CLRB) jumped 33.8% to $2.4357. Cellectar Biosciences announced up to $103 million private placement financing with certain institutional investors.
- Avalon GloboCare Corp. (NASDAQ: ALBT) gained 27% to $1.2250. Avalon GloboCare announced a notice of publication for key U.S. patent filed jointly with the Massachusetts Institute of Technology.
- GD Culture Group Limited (NASDAQ: GDC) shares gained 24.9% to $3.460 after the company said AI Catalysis Corp. has launched an interactive livestreaming game on TikTok.
- Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 24.1% to $9.16 after gaining around 9% on Friday.
- Wheels Up Experience Inc. (NYSE: UP) gained 24% to $2.4701.
- Canopy Growth Corporation (NASDAQ: CGC) gained 23% to $0.6660.
- EpicQuest Education Group International Limited (NASDAQ: EEIQ) gained 21.1% to $1.2959.
- Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 19.7% to $0.5444.
- Aravive, Inc. (NASDAQ: ARAV) shares climbed 19.2% to $0.1669 after falling 6% on Friday.
- Cibus, Inc. (NASDAQ: CBUS) jumped 18.4% to $17.66.
- CXApp Inc. (NASDAQ: CXAI) gained 16% to $3.6511.
- Cabaletta Bio, Inc. (NASDAQ: CABA) surged 15.7% to $15.42. Citigroup initiated coverage on Cabaletta Bio with a Buy rating and announced a price target of $22.
- Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) gained 15.5% to $12.26. Olema Pharmaceuticals announced a private placement of approximately $130 million.
- Insmed Incorporated (NASDAQ: INSM) jumped 15% to $26.06 after the company released topline results from its Phase 3 ARISE study of ARIKAYCE for nontuberculous mycobacterial lung infection caused by Mycobacterium avium complex who had not started antibiotics.
- Getty Images Holdings, Inc. (NYSE: GETY) gained 12.9% to $4.9688.
- Brady Corporation (NYSE: BRC) gained 12.6% to $57.24 following better-than-expected quarterly results.
- Zai Lab Limited (NASDAQ: ZLAB) jumped 11.8% to $29.20.
- Addex Therapeutics Ltd (NASDAQ: ADXN) shares gained 11.4% to $0.5057 after the company said ADX71149 (JNJ-40411813) Phase 2 epilepsy clinical study is progressing well, with Cohort 1 completed and 80% of patients recruited into Cohort 2.
- SNDL Inc. (NASDAQ: SNDL) jumped 11.2% to $1.9573.
- Applied Molecular Transport Inc. (NASDAQ: AMTI) shares rose 10.3% to $0.2001 after falling 17% on Friday.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 9.3% to $1.3001. Crown Electrokinetics is scheduled to hold an investor update conference call on Sept. 18, 2023.
- fuboTV Inc. (NASDAQ: FUBO) gained 8.3% to $2.87.
- Airbnb, Inc. (NASDAQ: ABNB) jumped 7.6% to $142.86 after it was announced the company will join the S&P 500.
- NextGen Healthcare, Inc. (NASDAQ: NXGN) shares climbed 5.1% to $20.31. Thoma Bravo is in advanced talks to acquire NextGen Healthcare, Bloomberg reported.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- BioCardia, Inc. (NASDAQ: BCDA) fell 23.2% to $0.5982 after the company released interim efficacy results in the phase 3 pivotal CardiAMP cell therapy heart failure trial.
- Trinseo PLC (NYSE: TSE) dipped 23.2% to $8.26.
- AERWINS Technologies Inc. (NASDAQ: AWIN) fell 22.4% to $0.1576.
- 1847 Holdings LLC (NYSE: EFSH) fell 22.3% to $0.0932 after the company announced notification of NYSE American listing deficiency.
- Aditxt, Inc. (NASDAQ: ADTX) shares fell 21.3% to $32.47. Aditxt recently announced a $10 million private placement priced at-the-market under Nasdaq rules.
- TradeUP Acquisition Corp. (NASDAQ: UPTD) shares fell 20.9% to $16.24 after jumping 201% on Friday.
- Manchester United plc (NYSE: MANU) shares fell 16.5% to $19.76 following a report suggesting the Glazer family will take the club off the market after failing to close a deal at their asking price.
- Edible Garden AG Incorporated (NASDAQ: EDBL) fell 16.4% to $1.6609 after jumping 54% on Friday.
- Axcella Health Inc (NASDAQ: AXLA) fell 16% to $0.35.
- Inspire Veterinary Partners, Inc. (NASDAQ: IVP) dipped 15.8% to $3.19.
- SeqLL Inc. (NASDAQ: SQL) fell 15.6% to $15.10.
- WeWork Inc. (NYSE: WE) dipped 14.7% to $3.75. WeWork announced a 1-for-40 reverse stock split.
- The Aaron's Company, Inc. (NASDAQ: AAN) fell 13.9% to $10.55.
- Re/Max Holdings Inc (NYSE: RMAX) shares dipped 13.3% to $14.22.
- Hanryu Holdings, Inc. (NASDAQ: HRYU) shares fell 13.2% to $4.14 after jumping 20% on Friday.
- Better Choice Company Inc. (NYSE: BTTR) declined 13.1% to $0.1887.
- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) fell 12.3% to $12.94.
- uniQure N.V. (NASDAQ: QURE) fell 12% to $7.68. uniQure won FDA clearance of investigational new drug application for AMT-260 gene therapy for refractory mesial temporal lobe epilepsy.
- America's Car-Mart, Inc. (NASDAQ: CRMT) shares fell 11.8% to $100.15 following weak quarterly earnings. America's Car-Mart named Doug Campbell as CEO & board member.
- Hawaiian Electric Industries, Inc. (NYSE: HE) declined 11.1% to $13.39.
- Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) declined 10.8% to $1.3550.
- 8x8, Inc. (NASDAQ: EGHT) fell 10.4% to $2.82.
- NETGEAR, Inc. (NASDAQ: NTGR) dipped 8.8% to $11.92.
- Trip.com Group Limited (NASDAQ: TCOM) shares declined 8% to $37.15 following second-quarter results.
- SCWorx Corp. (NASDAQ: WORX) fell 8% to $0.2024 after jumping 22% on Friday.
- Pitney Bowes Inc. (NYSE: PBI) declined 8% to $3.03.
- Installed Building Products, Inc. (NYSE: IBP) fell 7.1% to $135.88.
- SRM Entertainment, Inc. (NASDAQ: SRM) shares fell 7% to $2.00 after jumping over 15% on Friday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.